Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Equity Income (2019 - 2024)

Historic Equity Income for Viemed Healthcare (VMD) over the last 6 years, with Q3 2024 value amounting to $96000.0.

  • Viemed Healthcare's Equity Income fell 6444.44% to $96000.0 in Q3 2024 from the same period last year, while for Jun 2025 it was $96000.0, marking a year-over-year increase of 11302.58%. This contributed to the annual value of -$954000.0 for FY2024, which is 29670.1% down from last year.
  • Latest data reveals that Viemed Healthcare reported Equity Income of $96000.0 as of Q3 2024, which was down 6444.44% from -$1.1 million recorded in Q2 2024.
  • Viemed Healthcare's Equity Income's 5-year high stood at $459000.0 during Q4 2021, with a 5-year trough of -$1.1 million in Q2 2024.
  • For the 5-year period, Viemed Healthcare's Equity Income averaged around $94631.6, with its median value being $84000.0 (2022).
  • Per our database at Business Quant, Viemed Healthcare's Equity Income surged by 147619.05% in 2021 and then plummeted by 91532.85% in 2024.
  • Viemed Healthcare's Equity Income (Quarter) stood at $55000.0 in 2020, then soared by 734.55% to $459000.0 in 2021, then plummeted by 82.14% to $82000.0 in 2022, then plummeted by 47.56% to $43000.0 in 2023, then soared by 123.26% to $96000.0 in 2024.
  • Its Equity Income was $96000.0 in Q3 2024, compared to -$1.1 million in Q2 2024 and $67000.0 in Q1 2024.